Kamble N, et al. – This trial gauged the role of umbilical cord serum (UCS) and autologous serum (AS) therapy in reepithelialization of corneal graft, following keratoplasty. It was inferred that maximum cases of postkeratoplasty corneal epithelial defect (ED) could be managed with artificial tears (AT) only. The serum therapy (AS/UCS) aided in a rapid reepithelialization of postkeratoplasty ED than AT. It could be regarded as a therapeutic choice for early epithelial healing.